Company
Headquarters: Hangzhou, China
Employees: 725
CEO: Mr. Ming Zhong
| Company | Market Cap (USD) |
|---|---|
| Intuitive | $201.46 B |
| EssilorLuxottica SA | $144.43 B |
| Becton, Dickinson and Company | $55.63 B |
| HOYA Corp | $50.63 B |
| Alcon Inc. | $39.46 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $968.50 B |
| Johnson & Johnson | $499.57 B |
| AbbVie | $405.28 B |
| Roche | $332.12 B |
| UnitedHealth Group | $304.72 B |
Kangji Medical Holdings Limited, through its subsidiaries, engages in the research, development, manufacture, and sale of minimally invasive surgical instruments and accessories in China. It offers disposable trocars, polymer ligation clips, disposable electrocoagulation forceps, and other types of disposable hand-held instruments; and reusable trocars, reusable forceps, and other reusable products, including veress needles, monopolar grasping forceps, and myomectomy surgical instrument sets. The company's products are used in obstetrics and gynecology, general surgery, urology, and thoracic surgery specialties. It primarily sells products to a network of distributors. The company was founded in 2004 and is headquartered in Hangzhou, China.
Kangji Medical Holdings Ltd has the following listings and related stock indices.
Stock: HKEX: 9997
Stock: FSX: 50J